cimadronate has been researched along with pd 98059 in 2 studies
| Studies (cimadronate) | Trials (cimadronate) | Recent Studies (post-2010) (cimadronate) | Studies (pd 98059) | Trials (pd 98059) | Recent Studies (post-2010) (pd 98059) |
|---|---|---|---|---|---|
| 105 | 3 | 4 | 4,939 | 3 | 1,001 |
| Protein | Taxonomy | cimadronate (IC50) | pd 98059 (IC50) |
|---|---|---|---|
| RAF proto-oncogene serine/threonine-protein kinase | Homo sapiens (human) | 2.8 | |
| Luciferin 4-monooxygenase | Photinus pyralis (common eastern firefly) | 6.3 | |
| Amine oxidase [flavin-containing] B | Rattus norvegicus (Norway rat) | 2.8 | |
| Prostaglandin G/H synthase 1 | Homo sapiens (human) | 1 | |
| Mitogen-activated protein kinase 1 | Homo sapiens (human) | 2.8 | |
| Dual specificity mitogen-activated protein kinase kinase 2 | Rattus norvegicus (Norway rat) | 4.2 | |
| Dual specificity mitogen-activated protein kinase kinase 1 | Rattus norvegicus (Norway rat) | 4.2 | |
| Dual specificity mitogen-activated protein kinase kinase 1 | Homo sapiens (human) | 2.4 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amano, S; Inagaki, Y; Kikuchi, S; Ohno, S; Okamoto, T; Takeuchi, M; Yamagishi, S; Yoshimura, A | 1 |
| Harada, A; Hirade, K; Ito, H; Kato, K; Kozawa, O; Matsuno, H; Oiso, Y; Tokuda, H | 1 |
2 other study(ies) available for cimadronate and pd 98059
| Article | Year |
|---|---|
Incadronate disodium inhibits advanced glycation end products-induced angiogenesis in vitro.
Topics: Animals; Cells, Cultured; Diphosphonates; Endothelial Growth Factors; Endothelium, Vascular; Flavonoids; Glycation End Products, Advanced; Humans; Intercellular Signaling Peptides and Proteins; Lymphokines; Neovascularization, Pathologic; NF-kappa B; Polyisoprenyl Phosphates; Promoter Regions, Genetic; Sesquiterpenes; Transcription Factor AP-1; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2002 |
Incadronate amplifies prostaglandin F2 alpha-induced vascular endothelial growth factor synthesis in osteoblasts. Enhancement of MAPK activity.
Topics: Alkyl and Aryl Transferases; Animals; Cell Line; Cloprostenol; Cycloheximide; Cyclooxygenase Inhibitors; Dinoprost; Diphosphonates; Endothelial Growth Factors; Enzyme Activation; Enzyme Inhibitors; Farnesyltranstransferase; Flavonoids; Gene Expression; Indoles; Indomethacin; Intercellular Signaling Peptides and Proteins; Lymphokines; Maleimides; Mice; Osteoblasts; Prostaglandins F, Synthetic; Protein Kinase C; RNA, Messenger; Sodium Fluoride; Tetradecanoylphorbol Acetate; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2003 |